How Francophone Africa Hospitals Import UK Medicines: Algeria, Cote d'Ivoire, DRC and Senegal

Francophone Africa covers more than twenty countries and close to 400 million people, from the Mediterranean edge of Algeria to the heart of Central Africa in the Democratic Republic of the Congo. For UK pharmaceutical suppliers and for the hospitals, importers and Ministry of Health programmes buying from them, this region is often treated as an afterthought in English-language procurement literature. In reality, the regulatory frameworks are well defined, the documentation expectations are consistent, and the supply opportunity is large and growing.

This guide is written for hospital pharmacy directors, licensed importers, procurement heads and regulatory affairs managers across Francophone Africa who source from the UK or are considering it. We cover the national regulators, the French-language documentation standards, the named patient and exceptional import pathways, and the logistics realities that shape lead times from London Heathrow to Algiers, Abidjan, Dakar, Kinshasa, Luanda and beyond. It is also relevant for UK wholesalers planning supply into a region where the assumptions from GCC or Anglophone African markets do not always transfer.

Euro Biom holds an MHRA Wholesale Dealer Authorisation, WDA(H) 59239, and supplies Francophone African hospitals and NGO programmes with branded medicines, generics, named patient products and shortage lines. Our documentation workflow is built around the French-language requirements that LNCPP, DPML, ACOREP, DPM and DMP submissions demand as standard.

Why Francophone Africa Looks to UK Suppliers

Francophone African hospitals have traditionally sourced from France, Belgium and North Africa-based manufacturers. Over the past five years, three pressures have shifted that pattern: unreliable post-pandemic supply from traditional European sources, the regional spread of falsified medicines that has forced procurement teams to insist on fully traceable chains of custody, and growing demand for specialty oncology, biologic and rare disease products that were never routinely stocked by local distributors.

UK wholesalers authorised under MHRA WDA sit in a useful position to fill those gaps. The WDA regime requires full Good Distribution Practice compliance, temperature-validated storage, named Responsible Person oversight, and complete batch traceability from manufacturer to the export crate. Certificates of Pharmaceutical Product are issued by the MHRA in the WHO format that every Francophone African regulator recognises. Heathrow connects directly or via Paris Charles de Gaulle to every major Francophone African capital, keeping air freight times manageable for temperature-sensitive products.

For procurement teams, the choice of UK supply is rarely about price. It is about documentation quality, the ability to source unregistered products under named patient rules, and the regulatory confidence that comes from buying from a jurisdiction with active post-market surveillance and public drug alert systems.

Algeria: LNCPP and the Ministere de l'Industrie Pharmaceutique

The Regulator

Algeria's pharmaceutical sector is overseen by the Ministere de l'Industrie Pharmaceutique, which was carved out as a separate ministry in 2020 to drive domestic production. Day-to-day regulatory work is run by the LNCPP (Laboratoire National de Controle des Produits Pharmaceutiques). The LNCPP handles marketing authorisation review, quality control testing on imported batches, and the programme d'enregistrement that every new medicine must pass through before reaching Algerian patients.

The state-owned PCH (Pharmacie Centrale des Hopitaux) is the central hospital procurement body for the public sector, and Saidal Group is the country's dominant domestic manufacturer. For imported specialty, biologic and oncology products, the PCH typically contracts licensed importers to source internationally, and this is where UK suppliers enter the picture. Read more about our Algeria supply service.

What Algerian Hospitals Need from a UK Supplier

Algerian hospitals and importers expect a full regulatory dossier translated into French, with the CPP, CoA, manufacturer's declaration, packaging inserts and RCP (Resume des Caracteristiques du Produit) all prepared to LNCPP standards. Arabic labelling is also required for patient-facing materials on the finished product. Registration dossiers must follow the CTD format, and LNCPP turnaround for a full registration can run twelve to eighteen months. For shortage or named patient lines, the exceptional import authorisation pathway is significantly faster and is the route most UK suppliers use.

Cote d'Ivoire: DPML and the Abidjan Gateway

The Regulator

The Direction de la Pharmacie, du Medicament et des Laboratoires (DPML) is the national medicines regulator. It sits under the Ministere de la Sante, de l'Hygiene Publique et de la Couverture Maladie Universelle and holds authority over registration, inspection, pharmacovigilance, and import authorisation for all pharmaceutical products entering Cote d'Ivoire.

The Nouvelle PSP-CI (Pharmacie de la Sante Publique) is the central procurement body for public-sector hospitals, and ARIP-CI coordinates private-sector pharmacy distribution. Major hospital buyers include the CHU de Cocody, CHU de Yopougon, CHU de Treichville, CHU de Bouake, PISAM and Hopital Mere-Enfant Dominique Ouattara. Read more about our Cote d'Ivoire supply service.

Why Abidjan Is a Regional Hub

Cote d'Ivoire is the economic gateway to Francophone West Africa. Felix Houphouet-Boigny International Airport and the Port of Abidjan handle significant pharmaceutical freight volumes, and the country's UEMOA membership means that cargo cleared through Abidjan can move on preferential terms into Senegal, Mali, Burkina Faso, Niger, Togo, Benin and Guinea-Bissau. UK suppliers frequently use Abidjan as the primary landing point for multi-country tender supply across the UEMOA bloc.

Democratic Republic of the Congo: ACOREP and DPM

The Regulators

The DRC operates a dual regulatory structure. ACOREP (Autorite Congolaise de Reglementation Pharmaceutique) was established in 2023 as the new-generation regulator and is progressively taking over authorisation, registration and inspection responsibilities. The DPM (Direction de la Pharmacie et du Medicament), under the Ministere de la Sante Publique, continues to handle operational import licensing and hospital supply oversight during the transition.

FEDECAME is the central essential medicines purchasing federation for the public sector. Major hospital buyers include the Hopital General de Kinshasa, the Cliniques Universitaires de Kinshasa and the Hopital du Cinquantenaire. The DRC is the largest Francophone African country by population and by pharmaceutical demand, and its mix of large Kinshasa tertiary hospitals, conflict-affected provinces in North Kivu, South Kivu and Ituri, and a substantial NGO-led humanitarian health sector makes it one of the most complex supply environments on the continent. Read more about our DRC supply service.

Air Freight Into the Interior

Kinshasa N'djili handles most international pharmaceutical arrivals, but domestic distribution into Goma, Bukavu and Lubumbashi often depends on internal air bridges run by specialist operators and, for humanitarian programmes, by UN agencies and NGOs. UK suppliers shipping to the DRC should plan for a split logistics route: air freight into Kinshasa with cold chain validation, followed by onward domestic distribution managed by the importing hospital or NGO.

Senegal: DPM Dakar

The Regulator

The DPM (Direction de la Pharmacie et du Medicament) is the national medicines regulator, sitting under the Ministere de la Sante et de l'Action Sociale. Senegal is a founder UEMOA member and an influential voice in West African pharmaceutical regulatory harmonisation. Major hospital buyers include the Hopital Principal de Dakar, CHU Aristide Le Dantec and the Hopital Dalal Jamm.

Dakar is the second regional air freight gateway alongside Abidjan, and the Port of Dakar handles pharmaceutical sea freight for non-cold-chain products destined for the wider region. Read more about our Senegal supply service.

Morocco: DMP and the North African Gateway

The Regulator

The DMP (Direction du Medicament et de la Pharmacie) under the Ministere de la Sante sits alongside a mature domestic pharmaceutical industry. Morocco is sometimes treated as a North African market rather than a Francophone African one, but the regulatory posture is closely aligned with the rest of the region: French-language dossiers, CPPs in WHO format, and a recognised exceptional import authorisation pathway for unregistered medicines.

Casablanca is the main pharmaceutical air freight hub, with Rabat and Marrakech serving regional hospital supply. Major hospital buyers include the CHU Ibn Sina in Rabat, CHU Ibn Rochd in Casablanca, and the specialist oncology centres at the Institut National d'Oncologie. Read more about our Morocco supply service.

Documentation Standard for Francophone Africa

Whichever country you are shipping into, the core documentation package a UK supplier should prepare looks broadly the same. Small country-specific variations exist, but a well-prepared base package covers eighty per cent of any submission.

Named Patient and Exceptional Import Pathways

Every Francophone African regulator has a version of the named patient or exceptional import pathway for medicines not registered locally. The legal terminology varies, but the underlying principle is consistent: a specific patient or patient group has a documented clinical need, no suitable alternative is registered, and the hospital or importer is authorised to bring in the unregistered product for that specific use.

These pathways are used most often for oncology biologics, enzyme replacement therapies for rare diseases, paediatric specialty formulations, emergency antimicrobials, and medicines experiencing temporary regional shortage. The UK supplier's role is to provide the product dossier, CPP, CoA and manufacturer declaration within a timeframe that allows the importing hospital to submit a complete authorisation request. Our named patient supply service is built specifically for this workflow, with French-language documentation prepared as part of the standard package.

Logistics: Heathrow to Francophone Africa

Direct and one-stop air freight from London Heathrow reaches every major Francophone African capital. Typical transit times for cleared, properly documented consignments are: Algiers under six hours, Casablanca under four hours, Dakar under seven hours, Abidjan under nine hours, Kinshasa under twelve hours, Luanda under twelve hours. Most of the end-to-end lead time, typically ten to eighteen working days, is consumed by documentation preparation and in-country customs rather than flight time.

Cold chain shipments of biologics, insulins and vaccines run on validated passive cold boxes with GPS temperature loggers, or on active pharma-grade containers for larger consignments. For shortage and named patient work, we hold stock at the Heathrow gateway so that approved orders can be dispatched within forty-eight hours of receipt of a signed import authorisation.

Who We Supply in Francophone Africa

Euro Biom works with three customer groups across the region. First, hospital pharmacy directors and tertiary hospital procurement teams sourcing specialty, oncology and named patient medicines. Second, licensed importers and distributors that serve national essential medicines lists and private-sector pharmacy chains. Third, international NGOs and humanitarian programmes operating in Sudan, eastern DRC, Sahel countries and other crisis contexts where conventional supply chains do not reliably deliver.

Our core compliance posture, MHRA WDA(H) 59239, GDP-compliant storage, named Responsible Person oversight, and WHO-format CPP issuance, is consistent across every customer type. What changes is the documentation workflow, the import authorisation pathway, and the logistics routing.

Common Questions from Francophone African Buyers

How do we start an enquiry with a UK supplier?

Send a product list with INN names, strengths and quantities, plus the destination country and buyer type (public hospital, private distributor, NGO programme). A UK supplier should respond within one working day with availability, approximate pricing and a documentation scope. For named patient requests, include the treating physician's letter and any supporting clinical documentation.

Can a UK supplier ship without an in-country agent?

Most Francophone African regulators require a locally licensed importer or hospital pharmacy to hold the import authorisation. The UK supplier ships on FCA, CPT or DDP terms to that local party, who handles in-country clearance. A UK supplier cannot hold the import authorisation directly.

What about pricing?

UK-sourced specialty medicines are typically priced above the lowest-cost local alternatives, which reflects the cost of MHRA-licensed storage, GDP-compliant handling, WHO-format documentation and Heathrow-based logistics. The procurement case for UK supply is built on documentation quality, traceability and named patient availability, not on being the cheapest source.

What happens when an import is refused at the border?

Most refusals result from documentation gaps: missing French translations, CPP issued in the wrong format, CoA that does not reference the shipped batch, or incomplete cold chain records. A UK supplier with experience in the region should build the documentation pack to survive first-pass regulator inspection. When a refusal happens, the hospital or importer requests the specific deficiency note, the UK supplier prepares the corrective document, and the shipment is re-presented. Allow three to seven working days for the correction cycle.